Research progress of resveratrol in the treatment of polycystic ovary syndrome
10.3760/cma.j.cn101441-20220831-00373
- VernacularTitle:白藜芦醇在多囊卵巢综合征治疗中的研究进展
- Author:
Qianjie ZHANG
1
;
Yu GAO
1
;
Jing YANG
1
;
Saijiao LI
1
Author Information
1. 武汉大学人民医院生殖医学中心 湖北省辅助生育与胚胎发育医学临床研究中心，武汉 430060
- Publication Type:Journal Article
- Keywords:
Polycystic ovary syndrome;
Resveratrol;
Insulin resistance;
Hyperandrogenism
- From:
Chinese Journal of Reproduction and Contraception
2023;43(11):1178-1182
- CountryChina
- Language:Chinese
-
Abstract:
Polycystic ovary syndrome (PCOS) is the most common reproductive endocrine and metabolic disease in women of childbearing age, which is characterized by ovulatory dysfunction, hyperandrogenemia, infertility and polycystic changes of the ovary, often accompanied by obesity, insulin resistance (IR) and impaired glucose tolerance. In recent years, its incidence has increased year by year, and there is no completely effective treatment. More and more studies have shown that resveratrol has potential therapeutic value for PCOS. This article mainly reviews the related research and mechanism progress of resveratrol in improving IR, glucose and lipid metabolism disorders, hyperandrogenism, inflammation and oxidative stress in PCOS, as well as the application of resveratrol in PCOS with infertility.
